This is not the most recent version of the article. View current version (4 AUG 2010)

Intervention Protocol

You have free access to this content

Aerosolized prostacyclin for acute lung injury (ALI) and acute respiratory distress syndrome (ARDS)

  1. Arash Afshari1,*,
  2. Jesper Brok2,
  3. Ann Merete Møller3,
  4. Jørn Wetterslev4

Editorial Group: Cochrane Anaesthesia Group

Published Online: 15 APR 2009

DOI: 10.1002/14651858.CD007733


How to Cite

Afshari A, Brok J, Møller AM, Wetterslev J. Aerosolized prostacyclin for acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) (Protocol). Cochrane Database of Systematic Reviews 2009, Issue 2. Art. No.: CD007733. DOI: 10.1002/14651858.CD007733.

Author Information

  1. 1

    Rigshospitalet, The Cochrane Anaesthesia Review Group & Copenhagen Trial Unit and Department of Paediatric and Obstetric Anaesthesia, Copenhagen, Denmark

  2. 2

    Hvidovre Hospital, Paediatric Department, Hvidovre, Denmark

  3. 3

    Herlev University Hospital, Department of Anaesthesiology, Herlev, Denmark

  4. 4

    Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

*Arash Afshari, The Cochrane Anaesthesia Review Group & Copenhagen Trial Unit and Department of Paediatric and Obstetric Anaesthesia, Rigshospitalet, Blegdamsvej 9, Afsnit 3342, rum 52, Copenhagen, 2100, Denmark. arriba.a@gmail.com. afshari@rocketmail.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 15 APR 2009

SEARCH

This is not the most recent version of the article. View current version (04 AUG 2010)

References

Additional references

Adhikari 2007
Altman 2003
Anderson 2003
  • Anderson MR. Update on pediatric acute respiratory distress syndrome. Respiratory Care 2003;48(3):261-76. [MEDLINE: 12667276]
Angus 2001
  • Angus DC, Musthafa AA, Clermont G, Griffin MF, Linde-Zwirble WT, Dremsizov TT, et al. Quality-adjusted survival in the first year after the acute respiratory distress syndrome. American Journal of Respiratory and Critical Care Medicine 2001;163(6):1389-94. [MEDLINE: 11371406]
Barrington 2007
Bekelman 2003
Bernard 1994
  • Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. American Journal of Respiratory and Critical Care Medicine 1994;149(3):818-24.
Brok 2008
  • Brok J, Thorlund K, Gluud C, Wetterslev J. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. Journal of Clinical Epidemiology 2008;61(8):763-9. [MEDLINE: 18411040]
Chan 2004
Dickersin 1990
  • Dickersin K. The existence of publication bias and risk factors for its occurrence. JAMA 1990;263(10):1359-85. [MEDLINE: 2406472]
Egger 1997
Eichelbrönner 1996
  • Eichelbrönner O, Reinelt H, Wiedeck H, Mezödy M, Rossaint R, Georgieff M, et al. Aerosolized prostacyclin and inhaled nitric oxide in septic shock--different effects on splanchnic oxygenation?. Intensive Care Medicine 1996;22(9):880-7. [MEDLINE: 8905421]
Gamble 2005
Higgins 2002
Higgins 2003
Higgins 2008
  • Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
Hoeper 2000
  • Hoeper MM, Olschewski H, Ghofrani HA, Wilkens H, Winkler J, Borst MM, et al. A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group. Journal of the American College of Cardiology 2000;35(1):176-82. [MEDLINE: 10636277]
Hollis 1999
Hutton 2000
Jain 2006
Keus 2009
  • Keus F, Wetterslev J, Gluud C, Gooszen HG, van Laarhoven CJ. Robustness assessments are needed to reduce bias in meta-analyses including zero-event randomized trials. American Journal of Gastroenterology 2009;104(3):546-51. [PUBMED: 19262513 ]
Lan 1983
Luhr 1999
  • Luhr OR, Antonsen K, Karlsson M, Aardal S, Thorsteinsson A, Frostell CG, et al. Incidence and mortality after acute respiratory failure and acute respiratory distress syndrome in Sweden, Denmark, and Iceland. The ARF Study Group. American Journal of Respiratory and Critical Care Medicine 1999;159(6):1849-61. [MEDLINE: 10351930]
MacCallum 2005
Moloney 2003
Murray 1988
Phua 2009
  • Phua J, Badia JR, Adhikari NK, Friedrich JO, Fowler RA, Singh JM, et al. Has Mortality from Acute Respiratory Distress Syndrome Decreased Over Time? A Systematic Review. American Journal of Respiratory and Critical Care Medicine 2009;179(3):220-7. [PUBMED: 19011152]
Piantadosi 2004
Pogue 1997
Pogue 1998
RevMan 5.0
  • The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.0. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008.
Rücker 2008
Schuster 2008
  • Schuster KM, Alouidor R, Barquist ES. Nonventilatory interventions in the acute respiratory distress syndrome. Journal of Intensive Care Medicine 2008;23(1):19-32. [MEDLINE: 18230633]
Siobal 2003
  • Siobal MS, Kallet RH, Pittet JF, Warnecke EL, Kraemer RW, Venkayya RV, et al. Description and evaluation of a delivery system for aerosolized prostacyclin. Respiratory Care 2003;48(8):742-53. [MEDLINE: 12890294]
Siobal 2004
  • Siobal M. Aerosolized prostacyclins. Respiratory Care 2004;49(6):640-52. [MEDLINE: 15165299]
Sutton 2002
  • Sutton AJ, Cooper NJ, Lambert PC, Jones DR, Abrams KR, Sweeting MJ. Meta-analysis of rare and adverse event data. Expert Review in Pharmacoeconomics Outcomes Research 2002;2:367-79.
Sweeting 2004
TenHoor 2001
Ware 2000
Wetterslev 2008
Wetzel 1995